Remove Doctors Remove Life Science Remove Medicine Remove Pharma Companies
article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Google is also giving health records another whirl.

Pharmacy 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Frontiers Health Steering Committee spotlight – Paul Tunnah

pharmaphorum

Because digital permeates every aspect of the industry, and people are often talking about digital and maybe talking about very different things, I think about the journey of healthcare and life science companies in three stages,” he explained. The first stage of digital transformation was really all about communications.

article thumbnail

Veeva Systems Summit, Madrid – pharmaphorum reflects

pharmaphorum

Veeva Systems invited pharmaphorum to attend its industry summit in Madrid this week, a huge event that gathered together over 1,000 individuals from life sciences and pharma. The question is, how can the journey there be accelerated, when on the horizon awaits a life sciences future very much immersed in speciality medicine?

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . According to an article by Stephens, Zachary D., on Big data: astronomical or genomical? ,

article thumbnail

Sohonos (Palovarotene) Sets Milestone as First Drug for Ultra-Rare Bone Disease

XTalks

“The FDA approval of Sohonos is a breakthrough for the US FOP community,” said Howard Mayer, head of R&D at Ipsen, in the company’s news release. Development of medicines for rare diseases takes commitment and belief from everyone involved.

Drugs 98
article thumbnail

Study finds unexpected prescription influencers in healthcare

pharmaphorum

As a patient goes through their prescribing journey, they meet many different people, and one’s meeting with their doctor may be brief compared to the time spent with others. Lapolla states one personnel member told him they are excited pharma reps are coming back because they provide valuable information and educational materials.

Nurses 98